Average Co-Inventor Count = 7.73
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vitae Pharmaceuticals, Inc. (54 from 85 patents)
2. Boehringer Ingelheim International Gmbh (13 from 1,535 patents)
3. Merck + Co., Inc. (7 from 4,770 patents)
4. Jiangsu Hengrui Medicine Company Ltd. (2 from 159 patents)
5. Shanghai Hengrui Pharmaceutical Co., Ltd. (2 from 100 patents)
6. Other (1 from 832,680 patents)
7. Vitae Pharmaceuticals, Inc./boehringer-ingelheim (1 from 1 patent)
65 patents:
1. 12312359 - Inhibitors of the menin-MLL interaction
2. 11739085 - Inhibitors of the menin-MLL interaction
3. 11535614 - Dihydropyrrolopyridine inhibitors of ROR-gamma
4. 11535633 - Fused tricyclic heterocycle compounds and therapeutic uses thereof
5. 11479557 - Inhibitors of the menin-MLL interaction
6. 11332492 - CD73 inhibitors and therapeutic uses thereof
7. 11008340 - Modulators of ROR-gamma
8. 11001583 - Dihydropyrrolopyridine inhibitors of ROR-gamma
9. 10899758 - Inhibitors of the menin-MLL interaction
10. 10829481 - Benzimidazole derivatives as modulators of ROR-gamma
11. 10829448 - Substituted benzoimidazoles as modulators of ROR-γ
12. 10807980 - Dihydropyrrolopyridine inhibitors of ROR-gamma
13. 10683302 - Inhibitors of the menin-MLL interaction
14. 10399976 - Dihydropyrrolopyridine inhibitors of ROR-gamma
15. 10301261 - Substituted indoles as modulators of ROR-gamma